Search results

Jump to navigation Jump to search
  • A type II [[statin]] formerly used to treat high cholesterol levels ([[hypercholesterolemia]]).
    131 bytes (15 words) - 02:04, 4 July 2008
  • Small lipoproteins with a core composed mainly of cholesterol esters and some triglycerides.
    128 bytes (16 words) - 08:25, 12 February 2009
  • ...], which diminishes the production of [[mevalonate]], a key precursor of [[cholesterol]]. It is a class i statin and it similar in structure and function to othe
    491 bytes (62 words) - 08:34, 8 June 2009
  • A type of cholesterol found in or with high-density lipoproteins (HDL).
    107 bytes (14 words) - 07:21, 25 June 2023
  • ...>{{Subpages}}</noinclude>A component of [[bile]] structurally related to [[cholesterol]] and [[steroid]]s.
    116 bytes (14 words) - 10:17, 11 December 2010
  • ...>{{Subpages}}</noinclude>A component of [[bile]] structurally related to [[cholesterol]] and [[steroid]]s.
    116 bytes (14 words) - 10:05, 11 December 2010
  • Sold as Lipitor®, a type II [[statin]] used to treat high [[cholesterol]] ([[hypercholesterolemia]]),
    138 bytes (16 words) - 17:27, 1 July 2008
  • ...>{{Subpages}}</noinclude>A component of [[bile]] similar in structure to [[cholesterol]] and [[steroid]]s.
    116 bytes (15 words) - 09:41, 11 December 2010
  • A type II [[statin]], marketed as '''Crestor®''', used to treat high cholesterol levels.
    125 bytes (17 words) - 13:14, 8 July 2008
  • ...rophenyl-based [[statin]], HMG-CoA reductase inhibitor, for reduction of [[cholesterol]], [[triglyceride]]s and [[apo B]].
    162 bytes (17 words) - 13:27, 4 July 2008
  • [[Antilipemic agent|Antilipemic ]] [[medication]] which reduces both [[cholesterol]] and [[triglyceride]]s in the blood.
    156 bytes (17 words) - 00:08, 22 February 2009
  • ...tase decreases production of [[mevalonate]], a key chemical precursor of [[cholesterol]].
    1 KB (185 words) - 08:03, 8 June 2009
  • A crosslinked basic anion exchange resin used to reduce [[cholesterol]]. It may also may reduce [[triglyceride]] levels.
    156 bytes (20 words) - 02:19, 4 July 2008
  • ...]] inhibitors which reduce [[3-hydroxy-3-methyl-glutaryl CoA]] and lower [[cholesterol]] synthesis.
    154 bytes (15 words) - 08:51, 9 December 2008
  • ...]] inhibitors which reduce [[3-hydroxy-3-methyl-glutaryl CoA]] and lower [[cholesterol]] synthesis.
    154 bytes (15 words) - 08:53, 9 December 2008
  • ...or in the biosynthesis of [[cholesterol]]. The statin drugs used to lower cholesterol are [[Hydroxymethylglutaryl-coenzyme A reductase inhibitor|HMG-CoA reductas
    720 bytes (97 words) - 08:34, 8 June 2009
  • *{{CZ:Ref:Dietschy 2004 Cholesterol metabolism in the central nervous system during early development and in th
    141 bytes (19 words) - 09:33, 7 January 2009
  • Presence of an abnormally large amount of cholesterol in the cells and plasma of the circulating blood.
    140 bytes (20 words) - 10:57, 7 September 2009
  • === Oxazolidinone-based cholesterol esterase transfer protein (CETP) inhibitors ===
    1 KB (151 words) - 13:53, 26 November 2010
  • <noinclude>{{Subpages}}</noinclude>[[Cholesterol]] bound to [[lipoprotein]]s that carry it from the [[liver]] to cells where
    202 bytes (31 words) - 14:44, 23 August 2010
View ( | ) (20 | 50 | 100 | 250 | 500)